PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast-logo

PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast

Education Podcasts >

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Marwan Sabbagh, MD, FAAN - Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?

2/19/2019
More
Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?

Duration:00:45:42

Stewart J. Tepper, MD, FAHS - Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?

2/19/2019
More
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?

Duration:01:01:33

Deborah I. Friedman, MD, MPH - Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?

2/19/2019
More
Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?

Duration:00:35:26

Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?

1/23/2019
More
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?

Duration:00:43:12

Richard S. Finkel, MD - Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden

1/18/2019
More
Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden

Duration:00:54:48

Mark S. Sulkowski, MD - Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

1/14/2019
More
Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Duration:01:23:27

Steven Brem, MD - Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era

1/9/2019
More
Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era

Duration:00:54:36

Joseph McEvoy, MD - Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options

1/4/2019
More
Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options

Duration:00:45:58

Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease

11/19/2018
More
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease

Duration:00:24:47

Hiroshi Mitsumoto, MD, DSc - Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis

10/19/2018
More
Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis

Duration:00:20:58

J. Sloan Manning, MD - Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America

8/27/2018
More
Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America

Duration:00:38:03

Bruce Cree, MD, PhD, MAS - Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS

7/9/2018
More
Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS

Duration:01:01:17

Barbara K. Burton, MD - The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU

6/19/2018
More
The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU

Duration:00:53:40

Robin Lachmann, MD, PhD - Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies

6/1/2018
More
Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies

Duration:00:14:35

Joseph McEvoy, MD - Advances in Tardive Dyskinesia: A Patient's Journey From Diagnosis to Management and the Role of New Therapies for Improved Outcomes

5/22/2018
More
Advances in Tardive Dyskinesia: A Patient's Journey From Diagnosis to Management and the Role of New Therapies for Improved Outcomes

Duration:00:25:47

Richard J. Barohn, MD - Taking Stock of Recent Clinical Research in Generalized Myasthenia Gravis: What Is the Potential Impact of New Therapies on Disease Management?

4/23/2018
More
Taking Stock of Recent Clinical Research in Generalized Myasthenia Gravis: What Is the Potential Impact of New Therapies on Disease Management?

Duration:00:22:50

Nancy L. Kuntz, MD - A Patient’s Journey From Diagnosis to Treatment: A Story on the Transformative Impact of Precision Medicine on Spinal Muscular Atrophy Management

4/16/2018
More
A Patient’s Journey From Diagnosis to Treatment: A Story on the Transformative Impact of Precision Medicine on Spinal Muscular Atrophy Management

Duration:00:33:38

Tracy A. Glauser, MD - Optimized Management of Lennox-Gastaut Syndrome: A Patient’s Journey From Initial Recognition to Treatment

4/11/2018
More
Optimized Management of Lennox-Gastaut Syndrome: A Patient’s Journey From Initial Recognition to Treatment

Duration:00:31:41

Todd Dylan Levine, MD - Navigating the Patient Journey From CIDP Diagnosis Through Initial Treatment and Onto Long-Term Maintenance Therapy

2/23/2018
More
Navigating the Patient Journey From CIDP Diagnosis Through Initial Treatment and Onto Long-Term Maintenance Therapy

Duration:00:32:37

Aaron Boster, MD - Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris

2/5/2018
More
Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris

Duration:00:41:21